Literature DB >> 849813

Gastric and duodenal ulcer healing under placebo treatment.

U Scheurer, L Witzel, F Halter, H M Keller, R Huber, R Galeazzi.   

Abstract

The healing time relation of 30 gastric and 15 duodenal ulcers was assessed by repeated endoscopic measurements of ulcer size on days 1, 21, and 42 of a 6-week period, during which a selected population of patients was being treated as outpatients on an inert placebo. Antacids in small amounts were only given in case of ulcer pain. There was evidence for a linear relationship between the absolute initial ulcer size and its reduction with the time in incompletely healed ulcers of both types. Their percentage reduction from the original size was 71% after 3 weeks in gastric and 83% in duodenal ulcers; 82% after 6 weeks in gastric and 83% in duodenal ulcers. The healing time course for both types of ulcers appeared to follow an exponential function. The calculated half-life was 1.7 weeks for gastric and 1.9 weeks for duodenal ulcers. The number of healed duodenal ulcers observed at the 3-week examination was significantly greater than that of healed gastric ulcers (P = 0.05). It is concluded that repeated measurements of the ulcer size before complete ulcer healing contribute to a optimal characterization of the healing time course. The calculated half-life of less than 2 weeks makes shorter control intervals reasonable for both types of ulcers. The ulcer half-life appears to be a more accurate criterion of the healing process than that of complete healing.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 849813

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  16 in total

1.  Effect of placebo on meal-stimulated gastric acid secretion and serum gastrin concentration. Studies in healthy volunteers and duodenal ulcer patients.

Authors:  M Feldman; C T Richardson
Journal:  Dig Dis Sci       Date:  1988-02       Impact factor: 3.199

2.  The refractory ulcer.

Authors:  D W Piper
Journal:  World J Surg       Date:  1987-06       Impact factor: 3.352

Review 3.  Current therapy in peptic ulcer.

Authors:  I N Marks
Journal:  Drugs       Date:  1980-10       Impact factor: 9.546

4.  Is upper gastrointestinal radiography necessary in the initial management of uncomplicated dyspepsia? A randomized controlled trial comparing empiric antacid therapy plus patient reassurance with traditional care.

Authors:  J D Goodson; J W Lehmann; J M Richter; J L Read; S Atamian; G A Colditz
Journal:  J Gen Intern Med       Date:  1989 Sep-Oct       Impact factor: 5.128

5.  Healing dynamics of traumatic gastric mucosal defects in the normal and hyperacid stomach.

Authors:  F Halter; G O Barbezat; R van Hoorn-Hickman; W A van Hoorn
Journal:  Dig Dis Sci       Date:  1980-12       Impact factor: 3.199

6.  Cimetidine vs placebo in duodenal ulcer therapy. Six-week controlled double-blind investigation without any antacid therapy.

Authors:  M J Collen; M R Hanan; J A Maher; M Rent; S E Stubrin; J F Arguello; L Gardner
Journal:  Dig Dis Sci       Date:  1980-10       Impact factor: 3.199

7.  Correlation of gastric ulcer healing features by endoscopy, stereoscopic microscopy, and histology, and a reclassification of the epithelial regenerative process.

Authors:  T Miyake; T Suzaki; M Oishi
Journal:  Dig Dis Sci       Date:  1980-01       Impact factor: 3.199

8.  Double-blind controlled trial of cimetidine in the healing of gastric ulcer.

Authors:  P J Ciclitira; R J Machell; J G Farthing; A P Dick; J O Hunter
Journal:  Gut       Date:  1979-08       Impact factor: 23.059

9.  A comparison of omeprazole and ranitidine for duodenal ulcer in South African patients. A multiracial study.

Authors:  I N Marks; M D Danilewitz; J A Garisch
Journal:  Dig Dis Sci       Date:  1991-10       Impact factor: 3.199

10.  Effect of H2-receptor blockade by ranitidine on ulcer healing and gastric acid secretion in patients with gastric and duodenal ulcers.

Authors:  H Forssell; G Koch
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.